Expression and significance of CD147 protein in prostate cancer

National Medical Journal of China

Volumn 89, Issue 26, 2009, Pages 1844-1846

  He, Hui Chan ^a   Han, Zhao Dong ^a   Dai, Qi Shan ^a   Zou, Jun ^a   Zhang, Yang ^a   Zhang, Zheng ^a   Liang, Yu Xiang ^a   Ye, Yong Kang ^a   Chen, Zhi Nan ^a   Zhong, Wei De ^a  

^a GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

CD147; Diagnosis; Prognosis; Prostate cancer

Indexed keywords

CD147 ANTIGEN; TUMOR MARKER;

AGED; ARTICLE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MALE; METABOLISM; PATHOLOGY; PROGNOSIS; PROSTATE; PROSTATE HYPERTROPHY; PROSTATE TUMOR;

AGED; ANTIGENS, CD147; HUMANS; MALE; NEOPLASM STAGING; PROGNOSIS; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84871302337     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2009.26.015     Document Type: Article

References (14)

1. Zhong WD, Liu LS, Liu WH, et al. A clinical study on prostate cancer diagnosis with cDNA macroarray. Chinese J Cancer Res, 2005, 17: 66-70.
2. Stamey TA, Caldwell M, McNeal JE, et al. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol, 2004, 172: 1297-1301.
3. 2005, 22: 860-861.
4. Dalberg K, Eriksson E, Eaberg U, et al. Gelatinase A, membrane typel matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer. World J Surg, 2000, 24: 334-340.
5. Franks LM. Latent carcinoma of the prostate. J Pathol, 1954, 68: 603-616.
6. Schmid HP, Stamey TA, McNeal JE, et al. Effect of the natural history on management of adenocarcinoma of the prostate. Urol A, 1994, 33: 144-148.
7. 2004, 25: 95-99.
8. Schrgder FH, Wildhagen MF, ERSPC. Screening for prostate cancer: evidence and perspectives. BJU Int, 2001, 88: 811-817.
9. Seitz C, Djavan B. Biological markers of prostate cancer. Ann Urol (Paris), 2006, 40: 329-335.
10. Jianxin S, Martin E, Hemler. Regulation of MMP-1 and MMP-2 production throughCD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res, 2001, 61: 2276.
11. Yi Tang, Marian T, Nakada, et al. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating ascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res, 2005, 65: 3193-3199.
12. Marieb EA, Zoltan Jones A, Li R, et al. Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production. Cancer Res, 2004, 64: 1229-1232.
13. 2004, 39: 570-571.
14. 2001, 22: 217-219.